Skip to main content
Clinical Trials/NCT01903642
NCT01903642
Terminated
Not Applicable

Study of the Proteome and Cytokines During Inflammatory Syndromes of Different Etiologies.

Centre Hospitalier Universitaire Dijon1 site in 1 country97 target enrollmentMarch 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inflammatory Disease
Sponsor
Centre Hospitalier Universitaire Dijon
Enrollment
97
Locations
1
Primary Endpoint
determination of usual parameters of inflammation
Status
Terminated
Last Updated
12 years ago

Overview

Brief Summary

The hypotheses of our research are based on the fact that various pathological states, infection, cancer, inflammatory disease, can induce an inflammatory syndrome, through different pathways, even though the clinical presentation can be identical. The identification of biological markers specific to an etiology would therefore allow a faster diagnosis and improve care for patients. We thus took an interest in the three groups of diseases most frequently responsible for an inflammatory syndrome, infections, cancers and auto-immune diseases. To achieve this, various methods will be used.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
February 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients presenting an inflammatory syndrome, defined by elevated C-reactive protein (CRP\>50mg/L), whose etiology is related to infection, cancer or an inflammatory disease.
  • Patients not on treatment (corticoids, immunosuppressive drugs) during the 7 days preceding inclusion
  • Age: 18-90 years
  • Patients covered by the National Health Insurance Agency
  • signed written informed consent form

Exclusion Criteria

  • - Any patient not meeting the inclusion criteria
  • Pregnant patients

Outcomes

Primary Outcomes

determination of usual parameters of inflammation

Time Frame: at baseline

Study Sites (1)

Loading locations...

Similar Trials